Efficacy of Oral Ivabradine in Patients Presenting With NSTEMI
Last updated on July 2021Recruitment
- Recruitment Status
- Completed
Summary
- Conditions
- NSTEMI
- Type
- Interventional
- Phase
- Phase 2Phase 3
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT04285736
- Collaborators
- National Heart Institute, Egypt
- Investigators
- Not Provided